Study record

A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c

Zempo H, Kim SJ, Fuku N et al. · Aging (Albany NY) · 2021

Human obs.SeveralEvidence tier BAlso: Animal study (in vivo)Also: Cell study (in vitro)

What this study reported

Reported that males but not females carrying the C allele of the m.1382A>C variant, which produces K14Q-MOTS-c, had a higher prevalence of type 2 diabetes, with the association concentrated in men in the lowest physical-activity tertile. In high-fat-fed male mice, administered MOTS-c was associated with lower weight and improved glucose tolerance while K14Q-MOTS-c was not, and K14Q-MOTS-c showed diminished insulin-sensitising activity in cells.

Limitations

Genetic associations are observational and restricted to East Asian cohorts, the physical-activity interaction is based on self-reported tertiles, and the supporting animal work used male mice of a single strain with female mice reported as unaffected.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman, mouse
System studiedMeta-analysis of three Asian cohorts genotyped for m.1382A>C, plus high-fat-fed mice given MOTS-c or K14Q-MOTS-c and cell experiments
Populationadults from three Japanese and multi-ethnic cohorts (J-MICC, MEC, TMM)
DesignGenetic association meta-analysis with supporting controlled animal and cell experiments
Sample size as reported27,527 participants across three cohorts
Control groupA-allele carriers within the same cohorts; vehicle and K14Q-MOTS-c comparison groups in mice
Route (data field only)Not reported
Endpoints measuredtype 2 diabetes prevalence; body weight; glucose tolerance; insulin sensitisation
Pathways measuredInsulin & glucose handling · AKT / mTOR / FOXO
Research areasMetabolic · Exercise · Aging
Evidence tierB — Other human study
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Adequate
Controls
Appropriate
Outcome validity
Clinical outcome
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.